← Back to Clinical Trials
Recruiting NCT06581952

NCT06581952 Chinese Poem Writing for Improving Mental Wellbeing

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06581952
Status Recruiting
Phase
Sponsor Hong Kong Metropolitan University
Condition Well-Being, Psychological
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-06-13
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Poem writing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2024-06-13 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This research proposal aims to explore the impact of poem writing on the well-being of adult volunteers serving patients recovering from mental illness in Hong Kong. The research design was a single-arm intervention study with 30 participants. The intervention consists of two sessions of poem writing, each lasting for 3 hours, led by experienced Chinese teachers or drama directors. The themes of the poems will focus on accomplishment, joy, and gratitude. The primary outcomes are mental well-being and happiness, measured using the Short Warwick-Edinburgh Mental Well-being Scale and a single-item happiness scale. Feasibility outcomes include recruitment rate, retention rate, and acceptability of the interventions. Secondary outcomes include depressive symptoms, anxiety, interest in poem writing, perceived benefits after the activity, and the number of successfully written poems. The proposal also includes plans for in-depth interviews with participants to gather qualitative data. The results will be analyzed descriptively and narratively, with no efficacy statistical tests due to the nature of this feasibility study. The proposal highlights the potential of poem writing as a therapeutic tool for volunteers serving patients recovering from mental illness, enhancing their overall well-being.

Eligibility Criteria

Inclusion Criteria: * Volunteers serving for people recovering from mental illness or other community residents * Aged 18 years old and above * Able to understand Cantonese and read Chinese Exclusion Criteria: * Physically or mentally unable to communicate * Unwilling to participate or give consent * Being involved in other similar activities or research

Contact & Investigator

Central Contact

Agnes Lai, PhD

✉ ayklai@hkmu.edu.hk

📞 (852) 39702917

Principal Investigator

Agnes YK Lai

PRINCIPAL INVESTIGATOR

Hong Kong Metropolitan University

Frequently Asked Questions

Who can join the NCT06581952 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Well-Being, Psychological. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06581952 currently recruiting?

Yes, NCT06581952 is actively recruiting participants. Contact the research team at ayklai@hkmu.edu.hk for enrollment information.

Where is the NCT06581952 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT06581952 clinical trial?

NCT06581952 is sponsored by Hong Kong Metropolitan University. The principal investigator is Agnes YK Lai at Hong Kong Metropolitan University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology